Literature DB >> 15663397

Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.

Anna Alanen1, Kaisa Kahala, Tero Vahlberg, Pentti Koskela, Raija Vainionpää.   

Abstract

OBJECTIVE: To study seroprevalence and incidence and fetal transmission of varicella zoster virus (VZV), cytomegalovirus (CMV), herpes simplex virus (HSV) types 1 and 2 and parvovirus B19 infections during pregnancy and to evaluate the reliability of maternal past history of VZV, HSV and parvovirus infections.
DESIGN: Prospective study of parturient women.
SETTING: South-Western Finland. PARTICIPANTS: Five hundred and fifty-eight parturient women.
METHODS: IgG and IgM antibodies against VZV, CMV, HSV-1 and -2, and parvovirus B19 were measured from maternal serum in the first trimester and at delivery and from cord serum, mother's own information of her past infections was compared with her serological status. MAIN OUTCOME MEASURES: Seroprevalence, seroconversions and fetal transmission of VZV, CMV, HSV and parvovirus B19, reliability of maternal history of VZV, HSV and parvovirus B19.
RESULTS: Seroprevalences were 96.2% for VZV, 56.3% for CMV, 54.3% for HSV, 46.8% for HSV-1, 9.3% for HSV-2 and 58.6% for parvovirus B19. Parity was associated with CMV seropositivity, maternal age differed only between HSV-2 seropositive and seronegative women, while area of residence (urban or rural) had no effect. Six seroconversions were observed: two VZV, one CMV and three parvovirus infections. No cases of primary HSV infections occurred. Fetal transmission was observed in two cases of parvovirus infection. No infants with anti-CMV IgM antibodies were born to CMV immunised women. False positive history of chickenpox was given only by 1.5% of the women, history of herpes infections was less reliable, and history of parvovirus infection was unreliable.
CONCLUSIONS: Seroprevalence and the risk of viral infections during pregnancy cannot be extrapolated from one pregnant population to another.

Entities:  

Mesh:

Year:  2005        PMID: 15663397     DOI: 10.1111/j.1471-0528.2004.00320.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  27 in total

1.  Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Authors:  Gisela Enders; Anja Daiminger; Lisa Lindemann; Frank Knotek; Ursula Bäder; Simone Exler; Martin Enders
Journal:  Med Microbiol Immunol       Date:  2012-03-08       Impact factor: 3.402

2.  High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.

Authors:  Adeola Fowotade; Iheanyi Omezuruike Okonko; Olajide Olubunmi Agbede; S T Suleiman
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

3.  Maternal exposure to sexually transmitted infections and schizophrenia among offspring.

Authors:  Keely Cheslack-Postava; Alan S Brown; Roshan Chudal; Auli Suominen; Jukka Huttunen; Helja-Marja Surcel; Andre Sourander
Journal:  Schizophr Res       Date:  2015-05-26       Impact factor: 4.939

Review 4.  Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka.

Authors:  S W P Lakmini Daulagala; Faseeha Noordeen
Journal:  Virusdisease       Date:  2018-07-06

5.  Seroepidemiology of cytomegalovirus infections in Croatia.

Authors:  Tatjana Vilibic-Cavlek; Branko Kolaric; Natasa Beader; Izabela Vrtar; Irena Tabain; Gordana Mlinaric-Galinovic
Journal:  Wien Klin Wochenschr       Date:  2016-09-06       Impact factor: 1.704

Review 6.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

7.  Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.

Authors:  J Mossong; N Hens; V Friederichs; I Davidkin; M Broman; B Litwinska; J Siennicka; A Trzcinska; P VAN Damme; P Beutels; A Vyse; Z Shkedy; M Aerts; M Massari; G Gabutti
Journal:  Epidemiol Infect       Date:  2007-10-24       Impact factor: 2.451

8.  Seroprevalence of parvovirus B19 in the German population.

Authors:  C Röhrer; B Gärtner; A Sauerbrei; S Böhm; B Hottenträger; U Raab; W Thierfelder; P Wutzler; S Modrow
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

9.  Prevalence of herpes simplex virus types 1 and 2 and associated sociodemographic variables in pregnant women attending king fahd hospital of the university.

Authors:  Obeid E Obeid
Journal:  J Family Community Med       Date:  2007-01

10.  Seroprevalence of varicella antibodies among pregnant women in Lyon-France.

Authors:  M Saadatian-Elahi; Y Mekki; C Del Signore; B Lina; T Derrough; E Caulin; J Thierry; P Vanhems
Journal:  Eur J Epidemiol       Date:  2007-05-30       Impact factor: 12.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.